Latest news
Iconovo adds business development experience with new CEO
So far, 2020 has brought several advancements for the Swedish dry powder inhaler company Iconovo. A major stepping stone was the change of CEO in April.…
Iconovo signs regional licensing agreement for ICOcap® formulations with BNC Korea
Iconovo announce that the company has signed a know-how license agreement granting BNC Korea Co Ltd the exclusive rights to use the know-how to manufacture…
Press releases
Sep 10, 2024, 12:45
News
IR
English
Correction
Regulatory
MAR
Corporate Action
Other
Sep 10, 2024, 10:04
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Other
Sep 10, 2024, 10:04
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Other
Jul 12, 2024, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q2
Jul 12, 2024, 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Q2
May 24, 2024, 17:35
News
IR
English
Report
Annual
May 21, 2024, 11:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
May 15, 2024, 13:50
News
IR
English
Regulatory
MAR
Corporate Action
Other
May 15, 2024, 13:50
News
IR
Swedish
Regulatory
MAR
Corporate Action
Other
May 06, 2024, 08:30
News
IR
Swedish
Corporate Action
Other
May 06, 2024, 08:30
News
IR
English
Corporate Action
Other
Apr 25, 2024, 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Report
Annual
Apr 19, 2024, 09:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Mar 11, 2024, 09:57
News
IR
Swedish
Corporate Action
Other
Mar 11, 2024, 09:57
News
IR
English
Corporate Action
Other
Mar 06, 2024, 13:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
Mar 05, 2024, 10:45
News
IR
English
Corporate Action
Other
Mar 05, 2024, 10:45
News
IR
Swedish
Corporate Action
Other
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
